Christine Gebski - 04 Aug 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
SVP, Filtration & Chromatography
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
04 Aug 2022
Net transactions value
-$815,785
Form type
4
Filing time
05 Aug 2022, 16:29:05 UTC
Previous filing
17 May 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale $815,785 -3,357 -9.8% $243.01 30,735 04 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $243.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.98 to $243.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

SVP, Filtration & Chromatography